- Brooklyn ImmunoTherapeutics (BTX) +38%.
- Regional Health Properties (RHE) +21%.
- Gaucho Group Holdings (VINO) +15%.
- Ashford Hospitality Trust (AHT) +15%.
- Ocugen (OCGN) +13% as COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2.
- DAVIDsTEA (DTEA) +10%.
- SuperCom (SPCB) +9% on new project in California worth $4M.
- BriaCell Therapeutics Corp. (BCTX) +9%.
- Enlivex Therapeutics Ltd. (ENLV) +8%.
- GeoVax Labs (GOVX) +8%.
- Palisade Bio (PALI) +8%.
- So-Young International (SY) +8%.
- SunLink Health Systems, Inc. (SSY) +4%.
- Sonnet BioTherapeutics Holdings (SONN) +7% on definitive agreement with New Life Therapeutics Pte. Ltd.
- BioNTech SE (BNTX) +6% as Indian authorities are in talks with Pfizer and BioNTech over an expedited approval pathway for the use of its COVID-19 vaccine.
- Abeona Therapeutics (ABEO) +6%.
- Vaccinex (VCNX) +6%.
- Americas Gold and Silver (USAS) +6%.
- Cocrystal Pharma (COCP) +6% after Update of its COVID-19 antiviral discovery programs.
- Gilat Satellite Networks (GILT) +6% on agreement with APAC based government corporation
- Atossa Therapeutics (ATOS) +6%.
- Marathon Digital Holdings (MARA) +5%.
- Takung Art (TKAT) +5%.